National
The Commission has observed that the contents of the news report, if true, raise the issue of violation of the journalist's human rights.
Digital Desk: The National Human Rights Commission (NHRC) India has taken the suo motu cognizance of
Cancer incidence is increasing in Russia, as is the worldwide occurrence of cancer…
Digital Desk: One health sector’s major development is the discovery of a cancer vaccine by Russia that is to be made available for its citizens at no cost. The statement was released by Andrey Kaprin, the head of the radiology medical research center affiliated with the Russian Ministry of Health. As recorded by The Daily Mail, the vaccine will be out on the market by early 2025.
This vaccine is meant for therapeutic use, that is, to assist cancer patients, not to stop the formation of tumors. Russian scientists insist that each shot will be unique for the individual patient, which fits with similar practices of developed countries. Still, more distinct priorities, like the kinds of cancer the program will focus on, its effectiveness, and how it is going to be administered, remain ill-defined. The name of the vaccine has not been provided till now.
Cancer incidence is increasing in Russia, as is the worldwide occurrence of cancer. For instance, more than 635,244 new cancer incidences were recorded in 2022 only, and the three leading kinds of cancer include colon, breast, and lung cancer. Out of the different approaches in individualized cancer vaccines, like this one, will help the body’s immune system to identify certain proteins from a patient’s tumor by using RNA from the cancer cells themselves.
Speaking more about the vaccine, President Vladimir Putin recently affirmed that Russian scientists are in the final stage of developing a vaccine. “We are very close to developing a cancer vaccine and a new generation of immunomodulatory products,” he said.
Russia’s attempt comes as there is an increasing campaign for individualized cancer vaccines across the world. For example, scientists from the University of Florida tried a similar vaccine on four individuals in the first quarter of this year.
Vaccines against some of the agents causing cancer, including human papillomavirus (HPV) and hepatitis B virus (HBV), are already in existence, but Russia’s development goes further. Remarkably, the country has done this before; during the pandemic, it developed the Sputnik V coronavirus vaccine, which is distributed in many countries.
This latest development could open the floodgates to more accessible and effective cancer treatment with hope to millions of patients.
Leave A Comment